Double-Blinded Prospective Randomized Clinical Trial Comparing Regular and Moses Modes of Holmium Laser Lithotripsy
- PMID: 32143552
- PMCID: PMC7247036
- DOI: 10.1089/end.2019.0695
Double-Blinded Prospective Randomized Clinical Trial Comparing Regular and Moses Modes of Holmium Laser Lithotripsy
Abstract
Objective: To compare regular and Moses modes of holmium laser lithotripsy during ureteroscopy in terms of fragmentation/pulverization and procedural times in addition to perioperative complications. Patients and Methods: After obtaining ethics approval, a prospective double-blinded randomized trial was conducted for patients undergoing holmium laser lithotripsy during retrograde ureteroscopy. Patients were randomly assigned to either regular or Moses modes. Patients and surgeons were blinded to the laser mode. Lumenis 120W generator with 200 Moses D/F/L fibers were used. Demographic data, stone parameters, perioperative complications, and success rates were compared. The degree of stone retropulsion was graded on a Likert scale from 0-no retropulsion to 3-maximum retropulsion. Results: A total of 72 patients were included in the study (36 per arm). Both groups were comparable in terms of age and preoperative stone size (1.4 cm vs 1.7 cm, p > 0.05). When compared with the regular mode, Moses mode was associated with significantly lower fragmentation/pulverization time (21.1 minutes vs 14.2 minutes; p = 0.03) and procedural time (50.9 minutes vs 41.1 minutes, p = 0.03). However, there were no significant differences in terms of lasing time (7.4 minutes vs 6.1 minutes, p > 0.05) and total energy applied to the stones (11.1 kJ vs 10.8 kJ, p > 0.05). Moses mode was associated with significantly less retropulsion (mean grade was 1.0 vs 0.5, p = 0.01). There were no significant differences between both modes in terms of intraoperative complications (11.1% vs 8.3%, p > 0.05), with one patient requiring endoureterotomy for stricture in the Moses group. Success rate at the end of 3 months was comparable between both groups (83.3% vs 88.4%, p > 0.05). Conclusion: Moses technology was associated with significantly lower fragmentation/pulverization and procedural times. The reduced fragmentation/pulverization time seen using Moses technology could be explained by the significantly lower retropulsion of stones during laser lithotripsy.
Keywords: holmium laser; laser lithotripsy; outcomes assessment; randomized clinical trial; technology assessment; ureteroscopy.
Conflict of interest statement
Dr. Mostafa M. Elhilali and Dr. Sero Andonian were consultants for Lumenis.
Figures
Similar articles
-
"VirtualBasket" ureteroscopic holmium laser lithotripsy: intraoperative and early postoperative outcomes.Minerva Urol Nephrol. 2022 Jun;74(3):344-350. doi: 10.23736/S2724-6051.21.04025-X. Epub 2021 Mar 26. Minerva Urol Nephrol. 2022. PMID: 33769013 Clinical Trial.
-
Use of the Moses Technology to Improve Holmium Laser Lithotripsy Outcomes: A Preclinical Study.J Endourol. 2017 Jun;31(6):598-604. doi: 10.1089/end.2017.0050. Epub 2017 Apr 25. J Endourol. 2017. PMID: 28340540 Free PMC article.
-
Moses technology in a stone simulator.Can Urol Assoc J. 2018 Apr;12(4):127-130. doi: 10.5489/cuaj.4797. Epub 2017 Dec 22. Can Urol Assoc J. 2018. PMID: 29319478 Free PMC article.
-
Use of the Stone Cone for prevention of calculus retropulsion during holmium:YAG laser lithotripsy: case series and review of the literature.Urol Int. 2009;82(3):356-60. doi: 10.1159/000209372. Epub 2009 May 11. Urol Int. 2009. PMID: 19440028 Review.
-
Does Moses technology improve the efficiency and outcomes of standard holmium laser lithotripsy? A systematic review and meta-analysis.Cent European J Urol. 2022;75(4):409-417. doi: 10.5173/ceju.2022.156. Epub 2022 Oct 28. Cent European J Urol. 2022. PMID: 36794033 Free PMC article. Review.
Cited by
-
Consultation on kidney stones, Copenhagen 2019: aspects of intracorporeal lithotripsy in flexible ureterorenoscopy.World J Urol. 2021 Jun;39(6):1673-1682. doi: 10.1007/s00345-020-03481-9. Epub 2020 Oct 16. World J Urol. 2021. PMID: 33067728 Free PMC article. Review.
-
Laser Technology Advancements in the Treatment of Benign Prostatic Hypertrophy.Curr Urol Rep. 2024 Apr;25(4):71-78. doi: 10.1007/s11934-024-01197-6. Epub 2024 Feb 13. Curr Urol Rep. 2024. PMID: 38349464 Review.
-
Comparison of Fragmentation and Dusting Modality Using Holmium YAG Laser during Ureteroscopy for the Treatment of Ureteral Stone: A Single-Center's Experience.J Clin Med. 2022 Jul 17;11(14):4155. doi: 10.3390/jcm11144155. J Clin Med. 2022. PMID: 35887919 Free PMC article.
-
Comparison of ureteoroscopy and laser stone fragmentation between Holmium: YAG laser with MOSES versus non-MOSES technology: a prospective single-center propensity score-matched analysis using similar laser settings.Ther Adv Urol. 2024 Aug 20;16:17562872241272974. doi: 10.1177/17562872241272974. eCollection 2024 Jan-Dec. Ther Adv Urol. 2024. PMID: 39165700 Free PMC article.
-
Moses and Moses 2.0 for Laser Lithotripsy: Expectations vs. Reality.J Clin Med. 2022 Aug 18;11(16):4828. doi: 10.3390/jcm11164828. J Clin Med. 2022. PMID: 36013067 Free PMC article. Review.
References
-
- Geraghty RM, Jones P, Somani BK. Worldwide trends of urinary stone disease treatment over the last two decades: A systematic review. J Endourol 2017;31:547–556 - PubMed
-
- Turney BW, Heers H. Trends in urological stone disease: A 5-year update of hospital episodes statistics. BJU Int 2016;118:785–789 - PubMed
-
- Winship B, Wollin DA, Carlos EC, et al. . Dusting efficiency of the Moses Holmium Laser: An automated in vitro assessment. J Endourol 2019;33:896–901 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical